Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-26-016343·Bellevue Group AG
Schedule 13G ownership disclosure
Jade Biosciences Inc
Common Stock · CUSIP: 008064206
Event date: 2025-12-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bellevue Group AG
Shares: 3,341,103.00 · Class: 6.8%
- Bellevue Asset Management AG
Shares: 3,341,103.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016343
- Form type
- SCHEDULE 13G
- Filer
- Bellevue Group AG
- CIK
- CIK 1674546
- Filed
- Feb 17, 2026
- Reporting period
- Dec 16, 2025
- Description
- Schedule 13G beneficial ownership